Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CollPlant Biotechnologies (CLGN) Non-Current Debt (2017)

CollPlant Biotechnologies filings provide 1 years of Non-Current Debt readings, the most recent being $3.6 million for Q4 2017.

  • On a quarterly basis, Non-Current Debt changed N/A to $3.6 million in Q4 2017 year-over-year; TTM through Dec 2017 was $3.6 million, a N/A change, with the full-year FY2017 number at $3.6 million, changed N/A from a year prior.
  • Non-Current Debt hit $3.6 million in Q4 2017 for CollPlant Biotechnologies.
  • In the past five years, Non-Current Debt ranged from a high of $3.6 million in Q4 2017 to a low of $3.6 million in Q4 2017.